Share this post on:

Product Name :
CXJ-2

Search keywords :
CXJ-2

drugId :
null

Target Vo:
Mitogen-activated protein kinase; ERK1/ERK2

Target Vo Short Name :
ERK

Moa_Name:
Mitogen-activated protein kinase; ERK1/ERK2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sun Yat-Sen University

Active Company_Name :
Sun Yat-Sen University

Active Indication_Name:
Liver Cirrhosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Taldefgrobep alfa In Vivo
CCR7 Antibody supplier
Phospho-PKA RII alpha (Ser99) Antibody: Phospho-PKA RII alpha (Ser99) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 46 kDa, targeting to Phospho-PKA RII alpha (Ser99). It can be used for WB,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Pig.

Share this post on:

Author: Interleukin Related